Another study by Yao et al. utilized a similar application, where EVs derived from anti-inflammatory M2 macrophages were able to inhibit cell migration and invasion in a glioma cell line by delivery of miRNA targeting the PI3K/AKT/mTOR signaling pathway [113]. This evidence concerns the gene AKT1 and glioma.